醫師介紹

Doctor Introduction

:::

醫師個人介紹

Sheng-Teng Huang
Sheng-Teng Huang

中醫部部主任、中醫內科主任

黃升騰 Sheng-Teng Huang

中醫部部主任、中醫內科主任
黃升騰醫師熱心教學,視病猶親。專長為腫瘤疾病暨開刀放化療後調理、消化系肝膽腸胃疾病(慢性肝炎、肝硬化、膽結石、胰臟炎、腸胃炎及消化性潰瘍等)、風濕免疫暨過敏性疾病(過敏性鼻炎、氣喘、蕁麻疹、濕疹皮膚炎及關節炎等)、慢性腎臟病。建議病人在身體上及心理上需鬆、靜、自然。飲食合宜,心情快樂,自然百病不侵,身體健康。 1960〜2022學術生涯科學影響力排行榜人選
2020、2021、2022、2023 年度科學影響力排行榜人選,為全球前 2%科學家
學術論文

期刊論文

期刊論文/Journal Paper
(作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄)
日期
1 賴香君(Hsiang-Chun Lai)、翁瑞君(Jui-Chun Weng)、黃慧琪(Hui-Chi Huang)、(Jin-Xuan Ho)、(Chao-Lin Kuo)、鄭如茜(Ju Chien Cheng)*、黃升騰(Sheng-Teng Huang)*,Solanum torvum induces ferroptosis to suppress hepatocellular carcinoma,JOURNAL OF ETHNOPHARMACOLOGY,2024 Dec,335():1-12 2024 . 12
2 唐萱庭(TANG HSUAN-TING)、黃升騰(Sheng-Teng Huang)、歐世宸(Shi-Chen Ou)*,Liberation from extracorporeal membrane oxygenation in a patient with severe COVID-19-associated acute respiratory distress syndrome using traditional Chinese medicine: A case report,Explore-The Journal of Science and Healing,2024 Dec,20(6): 2024 . 12
3 王韋然(Wang, Wei-Jan)、唐萱庭(TANG HSUAN-TING)、歐世宸(Shi-Chen Ou)、沈宛柔、陳崇裕(CHUNG-YU CHEN)、李易撰(Li, Yi-Chuan)、(Sui-Yuan Chang)、張為超(Wei-Chao Chang)、薛博仁(Hsueh, Po-Ren)、黃升騰(Sheng-Teng Huang)*、洪明奇(Mien-Chie Hung)*,Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula,CANCER LETTERS,2024 Nov,604():1-12 2024 . 11
4 賴香君(Hsiang-Chun Lai)、林冠妏(Kuan-Wen Lin)、林橙莉(Cheng-Li Lin)、歐世宸(Shi-Chen Ou)、林宏任(Hung-jen Lin)、鄭如茜(Ju Chien Cheng)、黃超俊(Chao-Chun Huang)、黃升騰(Sheng-Teng Huang)*、鄭隆賓(Long-Bin Jeng)*,Chinese herbal medicine alleviates renal impairment induced by immunosuppressants in patients post living donor liver transplantation,Journal of Traditional and Complementary Medicine,2024 Sep,-(-):--- 2024 . 09
5 黃廷宇(HUANG TING-YU)、歐世宸(Shi-Chen Ou)、黃維德(Wei-Te Huang)、林于娟(Lin yu chuan)、洪皓脩(Hao-Hsiu Hung)、張晋維(Chin-Wei Chang)、蕭凱元(Kai-Yuan Hsiao)、高翊瑋(Yi-Wei Kao)、張瑋珊(Wei-Shan Chang)、謝邦昌(Ben-Chang Shia)、黃升騰(Sheng-Teng Huang)*,Validation of the constitution in Chinese medicine questionnaires with the newly developed blood‑vacuity category: a rare Taiwanese case study,Advances in Traditional Medicine,2024 Jul,24():1205-1213 2024 . 07
6 賴香君(Hsiang-Chun Lai)、鄭如茜(Ju Chien Cheng)、葉晞彤(YIP HEI-TUNG)、鄭隆賓(Long-Bin Jeng)、黃升騰(Sheng-Teng Huang)*,Chinese herbal medicine decreases incidence of hepatocellular carcinoma in diabetes mellitus patients with regular insulin management,World Journal of Gastrointestinal Oncology,2024 Mar,16(3):0 2024 . 03
7 張正杰(Chang, Cheng-Chieh)、蘇惠珍(Su, Huey-Jen)、尤慧玲(You, Huey-Ling)、高照為(Kao, Chao-Wei)、洪怡錂(Hung, I-Ling)、黃升騰(Sheng-Teng Huang)*,Isatis indigotica Inhibits Influenza A Virus (H1N1) Virulent Protein Production and Autophagosome Accumulation,Journal of Herbal Medicine,2024 Feb,43(2024):100827 2024 . 02
8 張正杰(Chang, Cheng-Chieh)、尤慧玲(You, Huey-Ling)、蘇惠珍(Su, Huey-Jen)、洪怡錂(Hung, I-Ling)、高照為(Kao, Chao-Wei)、黃升騰(Sheng-Teng Huang)*,Anti-influenza A (H1N1) virus effect of gallic acid through inhibition of virulent protein production and association with autophagy,Food Science & Nutrition,2023 Nov,2023(00):1-11 2023 . 11
9 林岱穎(LIN DAI-YING)、黃維德(Wei-Te Huang)、林于娟(Ling yu chuan)、洪皓脩(Hao-Hsiu Hung)、歐世宸(Shi-Chen Ou)、張晋維(Chin-Wei Chang)、林宏恩(Lin Hung-En)、林亭延(Lin Ting yen)、張淨文(Ching-Wen Chang)、洪暉鈞(Hui-Chun Hung)、黃升騰(Sheng-Teng Huang)*,Prescription system to calculate precise doses of Chinese herbal medicine to avoid toxic effects,Heliyon,2023 Jun,9(6):e16612 2023 . 06
10 賴香君(Hsiang-Chun Lai)、林宏任(Hung-jen Lin)、施盈秀(Ying-Hsiu Shih)、周仁偉(Jen-Wei Chou)、林冠妏(Kuan-Wen Lin)、鄭隆賓(Long-Bin Jeng)、黃升騰(Sheng-Teng Huang)*,LipoCol Forte capsules reduce the risk of liver cancer: A propensity score-matched, nationwide, population-based cohort study,World Journal of Gastrointestinal Oncology,2023 May,15(5):828-842 2023 . 05
11 黃廷宇(HUANG TING-YU)、黃維德(Wei-Te Huang)、林于娟(Ling yu chuan)、洪皓脩(Hao-Hsiu Hung)、歐世宸(Shi-Chen Ou)、張晋維(Chin-Wei Chang)、林宏恩(Lin Hung-En)、林亭延(Lin Ting yen)、張淨文(Ching-Wen Chang)、洪暉鈞(Hui-Chun Hung)、黃升騰(Sheng-Teng Huang)*,Chinese Intelligence Prescription System improves prescription accuracy while decreasing labor and drug costs,BMC HEALTH SERVICES RESEARCH,2023 May,23(1):514 2023 . 05
12 陳柏恩(Chen Po En)、洪皓脩(Hao-Hsiu Hung)、黃維德(Wei-Te Huang)、葉宸瑄(Chen-Hsuan Yeh)、高翊瑋(Yi-Wei Kao)、謝邦昌(Ben-Chang Shia)、黃升騰(Sheng-Teng Huang)*,Chinese Herbal Medicine Improved Survival in Stage IV Breast Cancer Patients: Data Mining of the Incorporated Taiwan Cancer Registry Database and Hospital Database,INTEGRATIVE CANCER THERAPIES,2023 May,22():1-12 2023 . 05
13 楊新玲(Hsin-Ling Yang)、黃升騰(Sheng-Teng Huang)、(Zi-He Lyu)、(Asif Ali Bhat)、(Chithravel Vadivalagan)、(Yu-Lyu Yeh)、許游章(You-Cheng Hseu)*,The anti-tumor activities of coenzyme Q0 through ROS-mediated autophagic cell death in human triple-negative breast cells,Journal of Functional Foods,2023 Mar,102(105454):1-17 2023 . 03
14 賴香君(Hsiang-Chun Lai)、林宏任(Hung-jen Lin)、鄭隆賓(Long-Bin Jeng)、黃升騰(Sheng-Teng Huang)*,Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma,World Journal of Gastrointestinal Oncology,2023 Jan,15(1):19-35 2023 . 01
15 王韋然(Wang, Wei-Jan)、陳曄(Chen,Yeh)、蘇文琪(Wen-Chi Su)、劉儼毅(Yen-Yi Liu)、(Wan-Jou Shen)、張為超(Wei-Chao Chang)、黃升騰(Sheng-Teng Huang)、林振文(Lin, Cheng-Wen)、(Yu-Chuan Wang)、楊佳昕(Chia-Shin Yang)、(Mei-Hui Hou)、(Yu-Chi Chou)、吳永昌(Yang-Chang Wu)、王紹椿(Shao-Chun Wang)、洪明奇(Mien-Chie Hung)*,Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2,JOURNAL OF FOOD BIOCHEMISTRY,2022 Oct,46(10):e14354 2022 . 10
16 (Shuo-Min Hsu)、林宏任(Hung-jen Lin)、高翊瑋(Yi-Wei Kao)、李德茂(Li, Te-Mao)、謝邦昌(謝邦昌)*、黃升騰(Sheng-Teng Huang)*,Concurrent use of Chinese herbal medicine and anticoagulants may reduce major bleeding events,PLoS One,2022 Aug,17(8):e0271965 2022 . 08
17 顏加豪(Jia-hau Yen)、黃暐㨗(Wei-Chieh Huang)、林淑卿(Shu-Ching Lin)、黃怡紋(Yi-Wen Huang)、邱琬婷、蔡嘉哲(Gregory J. Tsay)、洪明奇(Mien-Chie Hung)*、黃升騰(Sheng-Teng Huang)*,Metabolic remodeling in tumor-associated macrophages contributing to antitumor activity of cryptotanshinone by regulating TRAF6-ASK1 axis,Molecular Therapy-Oncolytics,2022 Jun,22(26):158-174 2022 . 06
18 歐世宸(Shi-Chen Ou)、黃升騰(Sheng-Teng Huang)、林美辰(Lin, Mei-Chen)、陳汶吉(Wen-Chi Chen)、黃志平(Chi-Ping Huang)、林宏任(Hung-jen Lin)*,Effects of Chinese herbal medicine in patients with benign prostatic hyperplasia: A nationwide cohort study in Taiwan,INTERNATIONAL JOURNAL OF UROLOGY,2022 Mar,2022(): 2022 . 03
19 顏加豪(Jia-hau Yen)、邱琬婷、莊家如(CHUANG CHIA-JU)、楊新玲(Hsin-Ling Yang)、黃升騰(Sheng-Teng Huang)*,Improved Wound Healing by Naringin Associated with MMP and the VEGF Pathway,MOLECULES,2022 Mar,27(5):1695 2022 . 03
20 許游章(You-Cheng Hseu)、(Yu-Fang Tseng)、(Sudhir Pandey)、(Sirjana Shrestha)、(Kai-Yuan Lin)、林振文(Lin, Cheng-Wen)、(Chuan-Chen Lee)、黃升騰(Sheng-Teng Huang)、楊新玲(Hsin-Ling Yang)*,Coenzyme Q0 Inhibits NLRP3 Inflammasome Activation through Mitophagy Induction in LPS/ATP-Stimulated Macrophages,Oxidative Medicine and Cellular Longevity,2022 Jan,2022(): 2022 . 01
21 洪碩(HUNG SHUO-WEN)、廖元敬(Yuan-Ching Liao)、紀奕彰(Chi I Chang)、林亭延(Lin Ting yen)、林于娟(Ling yu chuan)、林宏任(Hung-jen Lin)、黃升騰(Sheng-Teng Huang)*,Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report,Explore-The Journal of Science and Healing,2021 Dec,(): 2021 . 12
22 洪瑞鴻(HUNG JUI-HUNG)、陳威傑(Chen, Wei-Chieh)、林美辰(Lin, Mei-Chen)、莊筱梅(Chuang, Hsiao-Mei)、王俊隆(Wang, Jiun-Long)、傅彬貴(Fu, Pin-Kuei)、林峻邦(Chun-Pang Lin)、黃升騰(Sheng-Teng Huang)*,Associations of Chinese Herbal Medicine Use with the Risks of Acute Exacerbation and Mortality in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study,JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE,2021 Aug,(): 2021 . 08
23 張家豪(Chia-Hao Chang)、林峻邦(Chun-Pang Lin)、(Iona MacDonald)、曲在雯(Tzai-Wen Chiu)、黃升騰(Sheng-Teng Huang)*,Resolution of a vocal fold polyp treated with Chinese herbal medicine: One case report with literature review,Journal of Herbal Medicine,2021 Jul,29():100486 2021 . 07
24 林佳慧(Chia-Hui Lin)、林峻邦(Chun-Pang Lin)、黃升騰(Sheng-Teng Huang)*,Successful intervention with Chinese herbal medicine for hyperthyroidism: Two case reports and a literature review,Explore-The Journal of Science and Healing,2021 Jul,14(4):344-350 2021 . 07
25 洪皓脩(Hao-Hsiu Hung)、黃超俊(Chao-Chun Huang)、林美辰(Mei-Chen Lin)、黃升騰(Sheng-Teng Huang)*、鄭隆賓(Long-Bin Jeng)*,Evaluation of delayed bleeding risks associated with partial hepatectomy: A nationwide population-based propensity score matching study,International Journal of Surgery,2021 Jun,1(90):105980 2021 . 06
26 黃升騰(Sheng-Teng Huang)、陳曄(Chen,Yeh)、張為超(Wei-Chao Chang)、陳筱凡(Chen Hsiao-Fan)、賴香君(Hsiang-Chun Lai)、林幼淳(Yu-Chun Lin)、王韋然(Wang, Wei-Jan)、王昱權(WANG YU-CHUAN)、楊佳昕(Yang, Chia-Shin)、王紹椿(Shao-Chun Wang)、洪明奇(Mien-Chie Hung)*,Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,Viruses-Basel,2021 May,13(5):826 2021 . 05
27 王禎佑(Chen-Yu Wang)、王堂權(Wang, Tang-Chuan)、梁文敏(Liang Wen-Miin)、(Chien-Hui Hung)、邱建勳(Chiou, Jian-Shium)、陳朝榮(Chao-Jung Chen)、蔡輔仁(Fuu-Jen Tsai)、黃升騰(Sheng-Teng Huang)、張大元、林亭旭(Ting-Hsu Lin)、廖秋菊(Chiu-Chu Liao)、黃少玫(Huang, Shao-Mei)、李德茂(Li, Te-Mao)*、林應如(Ying-Ju Lin)*,Effect of Chinese Herbal Medicine Therapy on Overall and Cancer Related Mortality in Patients with Advanced Nasopharyngeal Carcinoma in Taiwan,Frontiers in Pharmacology,2020 Dec,607413(): 2020 . 12
28 許游章(You-Cheng Hseu)、(Yu-Chi Chiang)、(Yugandhar Vudhya Gowrisankar)、(Kai-Yuan Lin)、黃升騰(Sheng-Teng Huang)、(Sirjana Shrestha)、(Geng-Ruei Chang)*、楊新玲(Hsin-Ling Yang)*,The In Vitro and In Vivo Anticancer Properties of Chalcone Flavokawain B through Induction of ROS-Mediated Apoptotic and Autophagic Cell Death in Human Melanoma Cells,Cancers,2020 Oct,12(10):2936 2020 . 10
29 歐世宸(Shi-Chen Ou)、林美辰(Mei-Chen Lin)、林宏任(Hung-jen Lin)、黃志平(Chi-Ping Huang)、黃升騰(Sheng-Teng Huang)*,Association between erectile dysfunction and fibromyalgia in male patients: A Taiwanese nationwide population-based cohort study,INTERNATIONAL JOURNAL OF UROLOGY,2020 Sep,2020(): 2020 . 09
30 許碩珉(Hsu, Sheng-Min)、林宏任(Hung-jen Lin)、林美辰(Mei-Chen Lin)、黃升騰(Sheng-Teng Huang)*,Increased incidence and recurrence rates of acute diverticulitis in patients with irritable bowel syndrome,Colorectal Disease,2020 Aug,2020(): 2020 . 08
31 鄭惟仁(Wei-Zen Cheng)、林筠嵐(Lin Yun-Lan)、蘇元智(Su Yuan-Chih)、林美辰(Mei-Chen Lin)、曾政興(Tseng Chang-Hsing)、林瑞模(Ruey-Mo Lin)、黃升騰(Sheng-Teng Huang)*,Post‑surgery cholecystectomy, hepatectomy, and pancreatectomy patients increase the risk of osteoporotic vertebral fracture,JOURNAL OF BONE AND MINERAL METABOLISM,2020 Aug,2020(): 2020 . 08
32 黃升騰(Sheng-Teng Huang)、賴香君(Hsiang-Chun Lai)、林幼淳(Yu-Chun Lin)、黃維德(Wei-Te Huang)、洪皓脩(Hao-Hsiu Hung)、歐世宸(Shi-Chen Ou)、林宏任(Hung-jen Lin)、洪明奇(Mien-Chie Hung)*,Principles and treatment strategies for the use of Chinese herbal medicine in patients at different stages of coronavirus infection,American Journal of Cancer Research,2020 Jul,10(7):2010-2031 2020 . 07
33 賴香君(Hsiang-Chun Lai)、林宏任(Hung-jen Lin)、高翊偉(Kao Yi-Wei)、汪開勛(Wang Kai-Hsun)、周仁偉(Jen-Wei Chou)、謝邦昌(Shia Ben-Chang)、黃升騰(Sheng-Teng Huang)*,Irritable bowel syndrome increases the risk of chronic obstructive pulmonary disease: A retrospective cohort study,Scientific Reports,2020 Jun,10(1):10008 2020 . 06
34 黃維德(Wei-Te Huang)、洪皓脩(Hao-Hsiu Hung)、高翊偉(Kao Yi-Wei)、歐世宸(Ou Shi Chen)、林于娟(Ling yu chuan)、鄭惟仁(Wei-Zen Cheng)、顏子榮(Yen Zi-Rong)、李艦(Li Jian)、陳銘芷(Chen Ming-Chih)、謝邦昌(Shia Ben-Chang)*、黃升騰(Sheng-Teng Huang)*,Application of Neural Network and Cluster Analyses to Differentiate TCM Patterns in Patients With Breast Cancer,Frontiers in Pharmacology,2020 May,11():670 2020 . 05
35 張正杰(Chang, Cheng-Chieh)、尤慧玲(You Huey-Ling)、黃升騰(Sheng-Teng Huang)*,Catechin inhibiting the H1N1 influenza virus associated with the regulation of autophagy.,Journal of the Chinese Medical Association,2020 Apr,83(4):386-393 2020 . 04
36 盧漢霖(Lu, Han-Lin)、蘇元智(Su, Yuan-Chih)、林美辰(Mei-Chen Lin)、孫茂峰(Mao-Feng Sun)、黃升騰(Sheng-Teng Huang)*,Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study,COMPLEMENTARY THERAPIES IN MEDICINE,2020 Mar,49():102332 2020 . 03
37 林幼淳(Yu-Chun Lin)、黃超俊(Huang, Chao-Chun)、林美辰(Mei-Chen Lin)、黃升騰(Sheng-Teng Huang)*,Chinese herbal medicine reduces the risk of urinary incontinence in patients with chronic obstructive pulmonary disease: A populationbased retrospective cohort study,INTERNATIONAL JOURNAL OF UROLOGY,2020 Mar,2020(): 2020 . 03
38 張哲彬(Che-Pin Chang)、蘇元智(Yuan-Chih Su)、林美辰(Lin, Mei-Chen)、黃升騰(Sheng-Teng Huang)*,Chinese herbal medicine ameliorated the development of chronic kidney disease in patients with chronic hepatitis C - A retrospective population-based cohort study,Evidence-based Complementary and Alternative Medicine,2019 Oct,(): 2019 . 10
39 林祖功(Lin Tsu-Kung)、張永義(Chang Yung-Yee)、林宏昱(Lin Hung-Yu)、劉嘉為(Liou Chia-Wei)、王佩文(Wang Pei-Wen)、莊錦豪(Chuang Jiin-Haur)、陳尚德(Chen Shang-Der)、莊曜聰(Chuang Yao-Chung)、黃升騰(Sheng-Teng Huang)、許德耀(Hsu Te-Yao)、(Peng Cheng-Huei)、藍旻瑜(Lan Min-Yu)*,Mitochondrial dysfunctions in leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL),PLoS One,2019 Oct,14(10): 2019 . 10
40 林彩蕙(Tsai-Hui Lin)、陳書怡(Shu-I Chen)、蘇圓智(Su Yuan-Chih)、林美辰(Mei-Chen Lin)、林宏任(Hung-jen Lin)、黃升騰(Sheng-Teng Huang)*,Conventional Western Treatment Combined With Chinese Herbal Medicine Alleviates the Progressive Risk of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study,Frontiers in Pharmacology,2019 Sep,10():987 2019 . 09
41 黃升騰(Sheng-Teng Huang)*、許偉帆(Wei-Fan Hsu)、黃紘森(Huang Hung-Sen)、顏加豪(Jia-hau Yen)、林美辰(Mei-Chen Lin)、彭成元(Cheng-Yuan Peng)、顏宏融(Hung-Rong Yen)*,Improved Survival in Hepatocellular Carcinoma Patients with Cardiac Arrhythmia by Amiodarone Treatment through Autophagy,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2019 Aug,20(16):3978 2019 . 08
42 林祖功(Lin Tsu-Kung)、陳尚德(Chen Shang-Der)、莊曜聰(Chuang Yao-Chung)、藍旻瑜(Lan Min-yu)、莊錦豪(Chuang Jiin-Haur)、王佩文(Wang Pei-Wen)、許德耀(Hsu Te-Yao)、王逢興(Wang Feng-Sheng)、蔡孟翰(Tsai Meng-Han)、黃升騰(Sheng-Teng Huang)、王筱玟(Wang Xiao-Wen)、蔡伯鑫(Tsai Po-Chin)、林宏昱(Lin Hung-Yu)、劉嘉為(Liou Chia-Wei)*,Mitochondrial Transfer of Wharton’s Jelly Mesenchymal Stem Cells Eliminates Mutation Burden and Rescues Mitochondrial Bioenergetics in Rotenone-Stressed MELAS Fibroblasts,Oxidative Medicine and Cellular Longevity,2019 May,2019():9537504-9537521 2019 . 05
43 張家禎(Chia-Chen Chang)、(Kuo-Wei Bi,)、林宏任(Hung-jen Lin)、王玟玲(Wen-Ling Wang)、林振源(Lin, Chen-Yuan)、丁俊夫(Chun-Fu Ting)、孫茂峰(Mao-Feng Sun)、黃升騰(Sheng-Teng Huang)*,Conventional western treatment associated with Chinese herbal medicine ameliorates the incidence of head and neck cancer among patients with esophageal cancer,INTEGRATIVE CANCER THERAPIES,2019 Mar,18(): 2019 . 03
44 江坤俊(Chiang Kun-Chun)、黃升騰(Sheng-Teng Huang)、吳仁欽(Wu Ren-Chin)、黃仁聖(Huang Shih-Chiang)、葉大森(Yeh Ta-Sen)、陳明晃(Chen Ming-Huang)、徐潤德(Hsu Jun-Te)、陳立偉(Chen Li-Wei)、郭昇鋒(Kuo Sheng-Fong)、闕河晏(Chueh Ho-Yen)、莊宏亨(Juang Horng-Heng)、洪舜郁(Hung Shuen-Lu)、葉俊男(Yeh Chun-Nan)*、蘇中慧(S. Pang Jong-Hwei),Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival,Cancer Management and Research,2019 Feb,2019(): 2019 . 02
45 黃維德(Wei-Te Huang)、涂慶業(Chin-Yeh Tu)、王芬郁(Fen-Yu Wang)、黃升騰(Sheng-Teng Huang)*,Literature review of liver injury induced by Tinospora crispa associated with two cases of acute fulminant hepatitis,COMPLEMENTARY THERAPIES IN MEDICINE,2019 Feb,42(2019):286-291 2019 . 02
46 林于娟(Ling yu chuan)、黃維德(Wei-Te Huang)、歐世宸(Ou Shi Chen)、洪皓脩(Hao-Hsiu Hung)、鄭惟仁(Wei-Jen Cheng)、林聖興(Sheng-Shing Lin)、林宏任(Hung-jen Lin)、黃升騰(Sheng-Teng Huang)*,Neural network analysis of Chinese herbal medicine prescriptions for patients with colorectal cancer,COMPLEMENTARY THERAPIES IN MEDICINE,2019 Feb,42(2019):279-285 2019 . 02
47 顏加豪(Jia-hau Yen)、黃紘森(Huang Hung-Sen)、莊家如(CHUANG CHIA-JU)、黃升騰(Sheng-Teng Huang)*,Activation of dynamin-related protein 1-dependent mitochondria fragmentation and suppression of osteosarcoma by cryptotanshinone,JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,2019 Jan,38(42):1-15 2019 . 01
48 黃國欽(Huang, Kuo-Chin)、(Yuan-Chih Su)、孫茂峰(Mao-Feng Sun)、黃升騰(Sheng-Teng Huang)*,Chinese Herbal Medicine Improves the Long-Term Survival Rate of Patients With Chronic Kidney Disease in Taiwan: A Nationwide Retrospective Population-Based Cohort Study.,Frontiers in Pharmacology,2018 Oct,9(1117):1-10 2018 . 10
49 王禎佑(Chen-Yu Wang)、黃紘森(Huang Hung-Sen)、(Yuan-Chih Su)、涂智彥(Chih-Yen Tu)、夏德椿(Te-Chun Hsia)、黃升騰(Sheng-Teng Huang)*,Conventional treatment integrated with Chinese herbal medicine improves the survival rate of patients with advanced non-small cell lung cancer,COMPLEMENTARY THERAPIES IN MEDICINE,2018 Oct,40():29-36 2018 . 10
50 顏加豪(Jia-hau Yen)、黃升騰(Sheng-Teng Huang)*、黃紘森(Huang Hung-Sen)、(Yi-Chin Fong)、(Yi-Ying Wu)、(Jen-Huai Chiang)、(Yuan-Chih Su),HGK-sestrin 2 signaling-mediated autophagy contributes to antitumor efficacy of Tanshinone IIA in human osteosarcoma cells,Cell Death & Disease,2018 Sep,2018(9):1003-1019 2018 . 09
51 黃升騰(Sheng-Teng Huang)*、(Cheng-Chieh Chang)、(Jong-Hwei S. Pang)、(Hung-Sen Huang)、周聖杰(Shen-Chieh Chou)、高銘欽(Ming-Ching Kao)、(Huey-Ling You),Drynaria fortunei Promoted Angiogenesis Associated With Modified MMP-2/TIMP-2 Balance and Activation of VEGF Ligand/Receptors Expression,Frontiers in Pharmacology,2018 Sep,9(): 2018 . 09
52 陳暐棣(Wei-Di Chen)、黃紘森(Huang Hung-Sen)、(Yuan-Chih Su)、周聖杰(Shen-Chieh Chou)、何文照、高銘欽(Ming-Ching Kao)、林宏任(Hung-jen Lin)、黃升騰(Sheng-Teng Huang)*,The characteristics and prescription patterns of Chinese herbal medicine in clinical practice for the treatment of anemia,Taiwanese Journal of Obstetrics & Gynecology,2018 Aug,54(7):570-577 2018 . 08
53 尤慧玲(Huey-Ling You)、(Chao Chun Huang)、(Chung-Jen Chen)、(Cheng-Chin Chang)、(Pei-Lin Liao)、黃升騰(Huang, Sheng-Teng)*,Anti-pandemic influenza A (H1N1) virus potential of catechin and gallic acid,Journal of the Chinese Medical Association,2018 May,81(5):458-468 2018 . 05
54 李俐雯(Li-Wen Lee)、林宏任(Lin, Hung-Jen)、黃升騰(Huang, Sheng-Teng)*,Management of IFN-beta-induced flu-like symptoms with Chinese herbal medicine in a patient with multiple sclerosis: A case report,COMPLEMENTARY THERAPIES IN MEDICINE,2018 Jan,36(2018):123-128 2018 . 01
55 賴香君(Lai, Hsiang-Chun)、林宏任(Lin, Hung-Jen)、黃升騰(Huang, Sheng-Teng)*,Chinese herbal medicine to treat urolithiasis in a patient with right flank pain and hematuria: A case report,COMPLEMENTARY THERAPIES IN MEDICINE,2017 Dec,36(): 2017 . 12
56 黃國欽(Huang, kuo-Chin)、顏宏融(Yen, Hung-Rong)、蔣仁槐(Chiang, Jen-Huai)、(Yuan-Chih Su)、孫茂峰(Sun, Mao-Feng)、張恒鴻(Chang, Hen-Hong)、黃升騰(Huang, Sheng-Teng)*,Chinese Herbal Medicine as an Adjunctive Therapy Ameliorated the Incidence of Chronic Hepatitis in Patients with Breast Cancer: A Nationwide Population-Based Cohort Study,Evidence-based Complementary and Alternative Medicine,2017 Oct,2017(2017):1-9 2017 . 10
57 (Jong-Hwei S. Pang)、顏加豪(Jia-hau Yen)、(Hsiao-Ting Wu)、黃升騰(Huang, Sheng-Teng)*,Gallic Acid Inhibited Matrix Invasion and AP-1/ETS-1-Mediated MMP-1 Transcription in Human Nasopharyngeal Carcinoma Cells,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2017 Jun,18(7):1354-1367 2017 . 06
58 林彩蕙(Tsai-Hui Lin)、顏宏融(Hung-Rong Yen)、蔣仁槐(Chiang, Jen-Huai)、孫茂峰(SUN, MAO-FENG)、張恒鴻(CHANG,HEN-HONG)、黃升騰(Huang, Sheng-Teng)*,The use of Chinese herbal medicine as an adjuvant therapy to reduce incidence of chronic hepatitis in colon cancer patients: A Taiwanese population-based cohort study,JOURNAL OF ETHNOPHARMACOLOGY,2017 Apr,202():225-233 2017 . 04
59 黃升騰(Huang, Sheng-Teng)*、(Chao-Chun Huang)、黃紘森(Huang Hung-Sen)、(Tsu-Kung Lin)、(Pei-Lin Liao)、(Pei-Wen Wang)、(Chia-Wei Liou)、(Jiin-Haur Chuang),Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction,Scientific Reports,2017 Jan,7(40382):1-14 2017 . 01
60 (Chun-Ting Liu)、(Kuo-Wei Bi)、(Chao-Chun Huang)、(Hsiao-Ting Wu)、(Hui-Ya Ho)、(Jong- Hwei S. Pang)*、黃升騰(Huang, Sheng-Teng)*,Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/ TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells,JOURNAL OF ETHNOPHARMACOLOGY,2017 ,196(2017):213-2016接受 2017 .
61 黃升騰(Huang, Sheng-Teng)*、(Chao-Chun Huang)、(Jer-Ming Sheen)、(Tsu-Kung Lin)、(Pei-Lin Liao)、黃紘森(Huang Hung-Sen)、(Pei-Wen Wang)、(Chia-Wei Liou)、(Jiin-Haur Chuang),Phyllanthus urinaria’s Inhibition of Human Osteosarcoma Xenografts Growth in Mice is Associated with Modulation of Mitochondrial Fission/Fusion Machinery,AMERICAN JOURNAL OF CHINESE MEDICINE,2016 Oct,44(7):1-17 2016 . 10
62 (Woung-Ru Tang)*、(Sien-Hung Yang)、(Chih-Teng Yu)、(Chin-Chou Wang)、黃升騰(Huang, Sheng-Teng)、(Tzu-Hsin Huang)、(Ming-Chu Chiang)、(Yue-Cune Chang),Long-Term Effectiveness of Combined Treatment with Traditional Chinese Medicine and Western Medicine on the Prognosis of Patients with Lung Cancer,JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE,2016 Mar,22(3):212-222 2016 . 03
63 (Tun-Pin Hsueh)、(Jer-Ming Sheen)、(Jong-Hwei S. Pang)、(Kuo-Wei Bi)、(Chao-Chun Huang)、(Hsiao-Ting Wu)、黃升騰(Huang, Sheng-Teng)*,The Anti-Atherosclerotic Effect of Naringin Is Associated with Reduced Expressions of Cell Adhesion Molecules and Chemokines through NF-κB Pathway.,MOLECULES,2016 Feb,21(2):195 2016 . 02
64 (Hsin-Ning Chang)、黃升騰(Huang, Sheng-Teng)、(Yuan-ChiehYeh)、(Hsin-ShihWang)、(Tzu-Hao Wang)、(Yi-Hong Wu)、(Jong-HweiS.Pang)*,Indigo naturalis and its component tryptanthrin exert anti-angiogenic effect by arresting cell cycle and inhibiting Akt and FAK signaling in human vascular endothelial cells,JOURNAL OF ETHNOPHARMACOLOGY,2015 Nov,4(174):474-481 2015 . 11
65 (Hung-Yu Lin)、(Chia-Wei Liou)、(Shang-Der Chen)、(Te-Yao Hsu)、(Jiin-Haur Chuang)、(Pei-Wen Wang)、黃升騰(Huang, Sheng-Teng)、(Mao-Meng Tiao)、(Jin-Bor Chen)、(Tsu-Kung Lin)*、(Yao-Chung Chuang),Mitochondrial transfer fromWharton's jelly-derived mesenchymal stem cells to mitochondria-defective cells recaptures impaired mitochondrial function,MITOCHONDRION,2015 May,22():31-44 2015 . 05
66 鄭宇眞、沈哲民*、盧政男、黃升騰(Huang, Sheng-Teng),針藥併施治療偏頭痛經驗-病例報告,J Chin Med,2015 Jan,26(1):83-91 2015 . 01
67 黃博裕、吳清源、洪裕強、黃升騰(Huang, Sheng-Teng)、鄧雪妹、高照為、蔡明諺(Tsai, Ming-Yen)*,南臺灣偏遠地區中醫醫療服務滿意度及病患就診特性之研究,J Chin Med,2015 Jan,26(1):33-44 2015 . 01
68 (Rong-Chi Yang)、(Cheng-Chieh Chang)、(Jer-Ming Sheen)、(Hsiao-Ting Wu)、(Jong-Hwei S. Pang)、黃升騰(Huang, Sheng-Teng)*,Davallia bilabiata Inhibits TNF-α-Induced Adhesion Molecules and Chemokines by Suppressing IKK/NF-kappa B Pathway in Vascular Endothelial Cells,AMERICAN JOURNAL OF CHINESE MEDICINE,2014 Dec,42(6):1-19 2014 . 12
69 (Ming-Yen Tsai)、(Chun-Ting Liu)、(Cheng-Chieh Chang)、(Shih-Yu Chen)、黃升騰(Huang, Sheng-Teng)*,Overview of the relevant literature on the possible role of acupuncture in treating male sexual dysfunction,Acupuncture in Medicine,2014 Oct,32(5):406-410 2014 . 10
70 黃升騰(Huang, Sheng-Teng)*、(Kuo-Wei Bi)、(Hsiao-Mei Kuo)、(Tsu-Kung Lin)、(Pei-Lin Liao)、(Pei-WenWang)、(Jiin-Haur Chuang)、(Chia-Wei Liou),Phyllanthus urinaria induces mitochondrial dysfunction in human osteosarcoma 143B cells associated with modulation of mitochondrial fission/fusion proteins,MITOCHONDRION,2014 Jul,17():22-33 2014 . 07
71 (Cheng-Chieh Chang)、(Chen-Fu Chu)、(Chao-Nin Wang)、(Hsiao-Ting Wu)、(Kuo-Wei Bi)、(Jong-Hwei S. Pang)*、黃升騰(Huang, Sheng-Teng)*,The anti-atherosclerotic effect of tanshinone IIA is associated with theinhibition of TNF-α-induced VCAM-1, ICAM-1 and CX3CL1 expression,PHYTOMEDICINE,2014 Feb,21(3):207-216 2014 . 02
72 薛敦品、蔡明諺、胡文龍、黃升騰(Huang, Sheng-Teng)、洪裕強*,中醫系學生執業考試與實習表現相關性評估-以南部某醫學中心為例,J Chin Med,2014 Jan,25(1):73-81 2014 . 01
73 鄭宇真、胡文龍、蔡明諺、黃升騰(Huang, Sheng-Teng)、陳志文、洪裕強*,南部某醫學中心中醫常見疾病與處方用藥探討,J Chin Med,2014 Jan,25(1):83-96 2014 . 01
74 (Tsu-Kung Lin)、(Shang-Der Chen)、(Yao-Chung Chuang)、(Hung-Yu Lin)、(Chi-Ren Huang)、(Jiin-Haur Chuang)、(Pei-Wen Wang)*、黃升騰(Huang, Sheng-Teng)、(Mao-Meng Tiao)、(Jin-Bor Chen)、(Chia-Wei Liou),Resveratrol Partially Prevents Rotenone-Induced Neurotoxicity in Dopaminergic SH-SY5Y Cells through Induction of Heme Oxygenase-1 Dependent Autophagy,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2014 Jan,15(1):1625-1646 2014 . 01
75 沈哲民*、李冠東、黃升騰(Huang, Sheng-Teng)、盧政男、賴英秀(Lay Ing Shiow)、徐堅銘(HSU CHIEN MING)、何宗融(Tsung-Jung Ho),張仲景經方用藥一味差異影響治病範疇之研究,J Chin Med,2014 Jan,25(1):59-72 2014 . 01
76 (Huey-Ling You)、(Chung-Jen Chen)、(Hock-Liew Eng)、(Pei-Lin Liao)、黃升騰(Huang, Sheng-Teng)*,The Effectiveness and Mechanism of Toona sinensis Extract Inhibit Attachment of Pandemic Influenza A (H1N1) Virus,Evidence-based Complementary and Alternative Medicine,2013 Jul,2013():1-12 2013 . 07
77 (Tsu-Kung Lin)、(Hung-Yu Lin)、(Shang-Der Chen)、(Yao-Chung Chuang)、(Jiin-Haur Chuang)、(Pei-WenWang)、黃升騰(Huang, Sheng-Teng)、(Mao-Meng Tiao)、(Jin-Bor Chen)、(Chia-Wei Liou)*,The Creation of Cybrids Harboring Mitochondrial Haplogroups in the Taiwanese Population of Ethnic Chinese Background: An Extensive In Vitro Tool for the Study of Mitochondrial Genomic Variations,Oxidative Medicine and Cellular Longevity,2012 Oct,2012():1-13 2012 . 10
78 薛敦品、朱建福、黃升騰(Huang, Sheng-Teng)*,重症肌無力合併眼瞼下垂案例報告,J Chin Med,2012 Jul,24(1):167-174 2012 . 07
79 (Jiin-Haur Chuang)、(Tsu-Kung Lin)、(Ming-Hong Tai)、(Chia-Wei Liou)、黃升騰(Huang, Sheng-Teng)、(Chia-Ling Wu)、(Hung-Yi Lin)、(Pei-Wen Wang)*,Preferential involvement of mitochondria in Toll-like receptor 3 agonist-induced neuroblastoma cell apoptosis, but not in inhibition of cell growth,APOPTOSIS,2012 Apr,17(4):335-348 2012 . 04
80 (Hsin-Yi Wu)、(Tsu-Kung Lin)、(Hsiao-Mei Kuo)、(Ya-Ling Huang)、(Chia-Wei Liou)、(Pei-WenWang)、(Jiin-Haur Chuang)、黃升騰(Huang, Sheng-Teng)*,Phyllanthus urinaria Induces Apoptosis in Human Osteosarcoma 143B Cells via Activation of Fas/FasL- and Mitochondria-Mediated Pathways,Evidence-based Complementary and Alternative Medicine,2012 ,2012():1-13 2012 .
81 (Ming-Yen Tsai)、(Rong-Chi Yang)、(Hsiao-Ting Wu)、(Jong-Hwei S. Pang)、黃升騰(Huang, Sheng-Teng)*,Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells,CANCER LETTERS,2011 Nov,310(2):198-206 2011 . 11
82 (Hsei-Wei Wang)、(Kuo-Tong Liou)、(Yea-Hwey Wang)、(Chung-Kuang Lu)*、(Yun-Lian Lin)、(I-Jung Lee)、黃升騰(Huang, Sheng-Teng)、(Yuan-Hau Tsai)、(Yi-Chieh Cheng)、(Hung-Jui Lin)、(Yuh-Chiang Shen),Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice,JOURNAL OF ETHNOPHARMACOLOGY,2011 Oct,138(1):22-33 2011 . 10
83 黃升騰(Huang, Sheng-Teng)*、(Rong-Chi Yang)、(Hsiao-Ting Wu)、(Chao-Nin Wang)、(Jong-Hwei S. Pang),Zinc-Chelation Contributes to the Anti-Angiogenic Effect of Ellagic Acid on Inhibiting MMP-2 Activity, Cell Migration and Tube Formation,PLoS One,2011 May,6(5):e18986 2011 . 05
84 李冠東、黃升騰(Huang, Sheng-Teng)、(盧政男)、(洪裕強)、(沈哲民)*,胃食道逆流合併慢性胃炎中醫治療經驗-病例報告,J Chin Med,2011 Mar,22(3):231-237 2011 . 03
85 (Cheng-Chieh Chang)、黃升騰(Huang, Sheng-Teng)*,Is Traditional Chinese medicine effective for reducing hyperthyroidism?,JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE,2010 Nov,16(11):1217-1220 2010 . 11
86 林芸薇、黃升騰(Huang, Sheng-Teng)、(朱建福)*,小兒手術後腸沾黏之中醫治療經驗-案例報告,J Chin Med,2010 Oct,21(3):157-163 2010 . 10
87 黃升騰(Huang, Sheng-Teng)*、(Jong-Hwei S. Pang)、(Rong-Chi Yang),Anti-cancer effects of Phyllanthus urinaria and relevant mechanisms,Chang Gung Medical Journal,2010 Sep,33(5):477-487 2010 . 09
88 黃升騰(Huang, Sheng-Teng)*、(Chen-YuWang)、(Rong-ChiYang)、(Chih-JuChu)、(Hsiao-TingWu)、(Jong-HweiS.Pang),Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells,PHYTOMEDICINE,2010 Jan,17(1):47-54 2010 . 01
89 黃升騰(Huang, Sheng-Teng)、(Chen-Yu Wang)、(Rong-Chi Yang)、(Hsiao-Ting Wu)、(Su-Hui Yang)、(Yung-Chi Cheng)、(Jong-Hwei S. Pang)*,Ellagic Acid, the Active Compound of Phyllanthus urinaria, Exerts In Vivo Anti-Angiogenic Effect and Inhibits MMP-2 Activity,Evidence-based Complementary and Alternative Medicine,2009 Dec,2011():1-11 2009 . 12
90 黃升騰(Huang, Sheng-Teng)*、(Chen-Yu Wangb)、(Rong-Chi Yang)、(Chih-Ju Chu)、(Hsiao-Ting Wu),Phyllanthus urinaria increases apoptosis and reduces telomerase activity in human nasopharyngeal carcinoma cells,FORSCHENDE KOMPLEMENTARMEDIZIN,2009 Feb,16(1):34-40 2009 . 02
91 黃升騰(Huang, Sheng-Teng)、(Yashang Lee)、(Elizabeth A. Gullen)、(Yung-Chi Cheng)*,Impacts of baicalein analogs with modification of the 6th position of A ring on the activity toward NF-kappaB-, AP-1-, or CREB-mediated transcription,BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2008 Sep,18(18):5046-5049 2008 . 09
92 黃升騰(Huang, Sheng-Teng)*、(Gau-Yang Chen)、(Chien-Hui Wu)、(Cheng-Deng Kuo),Effect of disease activity and position on autonomic nervous modulation in patients with systemic lupus erythematosus,CLINICAL RHEUMATOLOGY,2008 Mar,27(3):295-300 2008 . 03
93 黃升騰(Huang, Sheng-Teng)*、(Annie Pei-Chun Chen),Traditional Chinese medicine and infertility,CURRENT OPINION IN OBSTETRICS & GYNECOLOGY,2008 ,20(3):211-215 2008 .
94 黃升騰(Huang, Sheng-Teng)、(Rong-Chi Yang)、(Pei-Nir Lee)、(Su-Hui Yang)、(Shuen-Kuei Liao)、(Tzu-Ya Chen)、(Jong-Hwei S. Pang)*,Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma,International Immunopharmacology,2006 Jun,6(6):870-879 2006 . 06
95 (Ching-Yuan Wu)、(Jong-Hwei S. Pang)、黃升騰(Huang, Sheng-Teng)*,Inhibition of melanogenesis in murine B16/F10 melanoma cells by Ligusticum sinensis Oliv,AMERICAN JOURNAL OF CHINESE MEDICINE,2006 ,34(3):523-533 2006 .
96 黃升騰(Huang, Sheng-Teng)*、(Gau-Yang Chen)、(Huey-Ming Lo)、林昭庚(Jaung-Geng Lin)、(Yin-Shiung Lee)、(Cheng-Deng Kuo),Increase in the vagal modulation by acupuncture at neiguan point in the healthy subjects,AMERICAN JOURNAL OF CHINESE MEDICINE,2005 ,33(1):157-164 2005 .
97 黃升騰(Huang, Sheng-Teng)*、(Rong-Chi Yang)、(Min-Yi Chen)、(Jong-Hwei S. Pang),Phyllanthus urinaria induces the Fas receptor/ligand expression and ceramide-mediated apoptosis in HL-60 cells,LIFE SCIENCES,2004 Jun,75(3):339-351 2004 . 06
98 黃升騰(Huang, Sheng-Teng)*、(Rong-Chi Yang)、(Jong-Hwei S. Pang),Aqueous extract of Phyllanthus urinaria induces apoptosis in human cancer cells,AMERICAN JOURNAL OF CHINESE MEDICINE,2004 ,32(2):175-183 2004 .
99 黃升騰(Huang, Sheng-Teng)*、(Rong-Chi Yang)、(Li-Jiun Yang)、(Pei-Nir Lee)、(Jong-Hwei S. Pang),Phyllanthus urinaria triggers the apoptosis and Bcl-2 down-regulation in Lewis lung carcinoma cells,LIFE SCIENCES,2003 Feb,72(15):1705-1716 2003 . 02

研討會論文

研討會論文/Conference Papers
(發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目)
日期
1 ,Taichung International Comprehensive Breast Cancer Symposium 2024台中國際乳癌研討會,中國醫藥大學 水湳校區 卓越大樓B2國際會議廳,2024.06.22~2024.06.23,View from traditional medicine: How to manage BC patients? 2024 . 06
2 運用PDCA 改善住院針灸會診遺針風險與事件數,2023年提升正向病安文化分享會,台大國際會議中心3樓301廳,2023.12.13~2023.12.13, 2023 . 12
3 A CASE REPORT OF MANAGEMENT OF POST-OPERATIVE HYPOTHYROIDISM WITH ZHEN WU TANG,19th meeting of Consortium for Globalization of Chinese Medicine(CGCM),Felton Gloria Grand Hotel Chengdu,2023.08.22~2023.08.24, 2023 . 08
4 建構中醫師臨床技能分級測驗初探—以針灸專科為例,台灣醫事聯合臨床技能發展學會2022年會員大會暨學術研討會,奇美醫院第五醫療大樓5樓國際會議廳,2022.10.1 ~2022.10.1 , 2022 . 10
5 PRELIMINARY EXPLORATION ON RESEARCH OF TRADITIONAL CHINESE MEDICINE FOR ESOPHAGEAL CANCER,21st International Congress of International society for Ethnopharmacology,中國醫藥大學水湳總校區 卓越大樓B2國際會議廳,2022.05.28~2022.05.31, 2022 . 05
6 Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study,2021第91屆國醫節第13屆台北國際中醫藥學術論壇,台大醫院國際會議中心,2021.03.13~2021.03.14, 2021 . 03
7 Conventional treatment integrated with Chinese herbal medicine improves the survival of patients with advanced non-small cell lung cancer,第19屆國際東洋醫學學術大會,National Taiwan University Hospital International Convention Center,2018.11.24~2018.11.26, 2018 . 11
8 Chinese herbal medicine to treat urolithiasis in a patient with right flank pain and hematuria: A case report,第19屆國際東洋醫學學術大會,National Taiwan University Hospital International Convention Center,2018.11.24~2018.11.26, 2018 . 11
9 接受標靶治療的肺癌病患之中醫辨證分型研究,第88屆國醫節中醫治療運動傷害學術研討會,中國醫藥大學立夫教學大樓地下一樓國際會議廳,2018.03.11~2018.03.11, 2018 . 03
10 中藥治療多發性硬化症患者IFN-β誘發的流感樣症狀: 個案報告,第八十八屆國醫節暨中醫治療運動傷害學術研討會,中國醫藥大學立夫教學大樓地下一樓國際會議廳(台中市北區學士路91號),2018.03.11~2018.03.11, 2018 . 03
11 The Poor Appetite and Traditional Chinese Medicine:Qi Deficiency and Phlegm Dampness,10th European Public Health Conference,Stockholm,2017.11.01~2017.11.04, 2017 . 11

專書

暫無資料

研究計畫

研究計畫/Research Grant
(研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,計畫期間)
日期
1 個別型,NSTC 113-2320-B-039-045,洪明奇(Mien-Chie Hung)、王陸海(Lu-Hai Wang),科技部,發現轉酮醇酶活化巨噬細胞於抗三陰性乳癌之機轉及透過其機轉篩選抗癌中藥-(2),2024.8.1~2025.7.31 2024 . 08
2 個別型,NSTC 113-2320-B-039-014,黃升騰(Sheng-Teng Huang),科技部,發展中醫大數據資料分析及應用模式–以中風為例,2024.8.1~2025.7.31 2024 . 08
3 個別型,MOHW113-CMAP-M-113-000002-C,,衛福部,113年度「建構中醫特色與智慧醫療模式計畫」分項二:數位新興科技結合中醫臨床實務應用模式計畫,2024.2.6~2024.12.15 2024 . 02
4 個別型,MOHW-113-CMB-03,孫茂峰(Mao-Feng Sun)、高尚德(Shung-Te Kao)、邱德發(Te-Fa Chiu)、黃升騰(Sheng-Teng Huang)、顏宏融(Hung-Rong Yen)、張東廸(Tung-Ti Chang)、蘇珊玉(Shan-Yu Su)、賴琬郁(Wan-Yu Lai)、李育臣(Yu-Chen Lee)、黃敬軒(Ching-Hsuan Huang)、黃國欽(Huang, Kuo-Chin)、徐新政(Hsu, Hsin-Cheng)、羅綸謙(Lun-Chien Lo)、林聖興(Sheng-Shing Lin)、黃明正(Ming-Cheng Huang)、林怡君(Yi-Chun Lin)、吳美瑤(Mei-Yao Wu)、葉祐安(Yu-An Yeh)、何婧嫙(Ching-Hsuan Ho),衛福部,113年度中醫臨床技能測驗及師資培訓計畫,2024.1.1~2024.12.15 2024 . 01
5 個別型,MOHW-113-CMA-08,黃敬軒(Ching-Hsuan Huang)、蘇珊玉(Shan-Yu Su)、賴琬郁(Wan-Yu Lai)、黃明正(Ming-Cheng Huang)、吳美瑤(Mei-Yao Wu),衛福部,113年中醫專科醫師訓練試辦計畫,2024.1.1~2024.12.15 2024 . 01
6 個別型,NSTC 112-2320-B-039-045,洪明奇(Mien-Chie Hung)、王陸海(Lu-Hai Wang),科技部,發現轉酮醇酶活化巨噬細胞於抗三陰性乳癌之機轉及透過其機轉篩選抗癌中藥,2023.8.1~2024.7.31 2023 . 08
7 個別型,MOHW-112-CM3B-03,洪明奇(Mien-Chie Hung)、薛博仁(Hsueh, Po-Ren)、何茂旺(Mao-Wang Ho)、歐世宸(Shi-Chen Ou)、黃維德(Wei-Te Huang)、李采娟(Tsai-Chung Li)、王韋然(Wang, Wei-Jan)、蔡邱轔(Chiu-Lin Tsai),衛福部,112年度「推動中藥創新研發計畫」,2023.5.17~2023.12.31 2023 . 05
8 個別型,MOHW112-CMAP-M-113-000006-C,,衛福部,112年度「建構中醫特色與智慧醫療模式計畫」分項二:數位新興科技結合中醫臨床實務應用模式計畫,2023.3.1~2023.12.15 2023 . 03
9 個別型,MOHW-111-CMB-03,孫茂峰(Mao-Feng Sun)、高尚德(Shung-Te Kao)、邱德發(Te-Fa Chiu)、黃升騰(Sheng-Teng Huang)、顏宏融(Hung-Rong Yen)、張東廸(Tung-Ti Chang)、羅綸謙(Lun-Chien Lo)、蘇珊玉(Shan-Yu Su)、賴琬郁(Wan-Yu Lai)、李育臣(Yu-Chen Lee)、黃敬軒(Ching-Hsuan Huang)、黃國欽(Huang, Kuo-Chin)、徐新政(Hsu, Hsin-Cheng)、林聖興(Sheng-Shing Lin)、黃明正(Ming-Cheng Huang)、林怡君(Yi-Chun Lin)、吳美瑤(Mei-Yao Wu)、葉祐安(Yu-An Yeh)、何婧嫙(Ching-Hsuan Ho),衛福部,112年度中醫臨床技能測驗及師資培訓計畫,2023.1.1~2023.12.15 2023 . 01
10 個別型,MOHW-112-CMA-8,黃敬軒(Ching-Hsuan Huang)、蘇珊玉(Shan-Yu Su)、賴琬郁(Wan-Yu Lai)、黃明正(Ming-Cheng Huang)、吳美瑤(Mei-Yao Wu),衛福部,112年中醫專科醫師訓練試辦計畫,2023.1.1~2023.12.15 2023 . 01
11 個別型,MOHW112-CMAP-M-124-000401-B,黃升騰(Sheng-Teng Huang),衛福部,112年度「精進中藥典品質及技術規範」,分項計畫3:中醫臨床應用規範編修與諮詢,2023.1.1~2023.12.31 2023 . 01
12 個別型,DMR-112-157,鄭隆賓(Long-Bin Jeng)、黃升騰(Sheng-Teng Huang)、林宏任(Hung-jen Lin)、賴香君(Hsiang-Chun Lai)、歐世宸(Shi-Chen Ou)、林橙莉(Cheng-Li Lin),附醫院內計畫,肝移植患者因抗排斥藥導致腎衰竭而接受中西醫合併照護之成果分析,2022.8.1~2023.6.30 2022 . 08
13 個別型,DMR-112-004,黃升騰(Sheng-Teng Huang),附醫院內計畫,研究本院濃縮科學中藥的藥物重複和藥物過量程度,以及其造成的潛在經濟損失和人體危害,2022.8.1~2023.7.31 2022 . 08
14 個別型,MOST 111-2320-B-039-025,王陸海(Lu-Hai Wang),科技部,轉酮醇酶於三陰性乳癌微環境中對腫瘤相關巨噬細胞的分化功能影響機轉並作為中草藥篩選之平台應用-2,2022.8.1~2023.7.31 2022 . 08
15 個別型,MOHW-111-CMA-08,林宏任(Hung-jen Lin)、黃敬軒(Ching-Hsuan Huang)、賴琬郁(Wan-Yu Lai)、蘇珊玉(Shan-Yu Su)、黃明正(Ming-Cheng Huang),衛福部,111年中醫專科醫師訓練計畫,2022.1.1~2022.12.15 2022 . 01
16 個別型,採購案號:M1107092,,衛福部,111年度「建構中醫特色與智慧醫療模式計畫」,分項2:數位新興科技結合中醫臨床實務應用模式計畫,2022.1.27~2022.12.15 2022 . 01
17 個別型,MOHW-111-CMB-03,孫茂峰(Mao-Feng Sun)、林嘉德(Chia-Der Lin)、邱德發(Te-Fa Chiu)、黃升騰(Sheng-Teng Huang)、顏宏融(Hung-Rong Yen)、羅綸謙(Lun-Chien Lo)、張東廸(Tung-Ti Chang)、林宏任(Hung-jen Lin)、蘇珊玉(Shan-Yu Su)、賴琬郁(Wan-Yu Lai)、李育臣(Yu-Chen Lee)、黃敬軒(Ching-Hsuan Huang)、黃國欽(Huang, Kuo-Chin)、徐新政(Hsu, Hsin-Cheng)、林聖興(Sheng-Shing Lin)、林怡君(Yi-Chun Lin)、謝宜庭(Yi-Ting Hsieh)、葉祐安(Yu-An Yeh)、何婧嫙(Ching-Hsuan Ho),衛福部,111年度輔導中醫臨床技能測驗及師資培訓計畫,2022.1.1~2022.12.15 2022 . 01
18 個別型,DMR-111-013,,附醫院內計畫,轉酮醇酶於三陰性乳癌微環境中對2型先天性淋巴樣細胞啟動與活化機轉,2021.8.1~2022.7.31 2021 . 08
19 個別型,CMU110-ASIA-09,黃升騰(Sheng-Teng Huang)、葉又綠,本校(含附醫),抗發炎/轉移/生物能量代謝/細胞自噬之腫瘤細胞及動物模式的建立,2021.8.1~2022.7.31 2021 . 08
20 個別型,DMR-111-005,黃升騰(Sheng-Teng Huang),附醫院內計畫,探討骨碎補藥膏促進糖尿病傷口癒合之相關分子機制,2021.8.1~2022.7.31 2021 . 08
21 個別型,MOST 110-2320-B-039-040,,科技部,轉酮醇酶於三陰性乳癌微環境中對腫瘤相關巨噬細胞的分化功能影響機轉並作為中草藥篩選之平台應用,2021.8.1~2022.7.31 2021 . 08
22 個別型,DMR-111-176,黃升騰(Sheng-Teng Huang)、黃維德(Wei-Te Huang),附醫院內計畫,中醫藥在泌尿系統癌症的影響,2021.8.1~2022.6.30 2021 . 08
23 個別型,DMR-111-016,黃升騰(Sheng-Teng Huang)、林宏任(Hung-jen Lin)、謝邦昌,附醫院內計畫,人工智慧自動判讀中醫舌診系統,2021.8.1~2022.7.31 2021 . 08
24 個別型,MOHW-110-CMA-06,林宏任(Hung-jen Lin)、黃明正(Ming-Cheng Huang)、黃敬軒(Ching-Hsuan Huang)、吳美瑤(Mei-Yao Wu)、賴香君(Hsiang-Chun Lai)、林幼淳(Yu-Chun Lin),衛福部,110年度「中醫專科醫師訓練試辦計畫」,2021.1.1~2021.12.15 2021 . 01
25 個別型,MOHW-110-CMB-03,孫茂峰(Mao-Feng Sun)、賴榮年(Jung-Nien Lai)、林嘉德(Chia-Der Lin)、邱德發(Te-Fa Chiu)、顏宏融(Hung-Rong Yen)、羅綸謙(Lun-Chien Lo)、張東廸(Tung-Ti Chang)、林宏任(Hung-jen Lin)、蘇珊玉(Shan-Yu Su)、賴琬郁(Wan-Yu Lai)、李育臣(Yu-Chen Lee)、黃敬軒(Ching-Hsuan Huang)、黃國欽(Huang, Kuo-Chin)、徐新政(Hsu, Hsin-Cheng)、林聖興(Sheng-Shing Lin)、侯甫葦(Pu-Wei Hou)、蔡邱轔(Chiu-Lin Tsai)、吳旻峰(Min-Feng Wu)、涂慶業(Chin-Yeh Tu)、詹士賢(Shyh-Shyan Jan)、李雅玲(Ya-Ling Lee)、邱奕笙(Yi-Sheng Ciou)、楊宗穎(Zong-Ying Yang)、何婧嫙(Ching-Hsuan Ho),衛福部,110年度中醫臨床技能測驗及臨床教學網絡計畫,2021.1.1~2021.12.15 2021 . 01
26 個別型,M1007073,,衛福部,110年度「建構中醫特色與智慧醫療模式計畫」,2021.1.1~2021.12.15 2021 . 01
27 個別型,採購案號:M09G1374,黃升騰(Sheng-Teng Huang)、林宏任(Hung-jen Lin)、林立偉,衛福部,109年度「研訂新增中藥製劑基準方計畫」,2020.8.18~2021.7.31 2020 . 08
28 個別型,DMR-110-009,黃升騰(Sheng-Teng Huang)、黃志平(Chi-Ping Huang)、陳汶吉(Wen-Chi Chen),附醫院內計畫,攝護腺癌病患的中醫體質與特性評估分析:觀察性研究,2020.8.1~2021.7.31 2020 . 08
29 個別型,CMU109-ASIA-10,黃升騰(Sheng-Teng Huang)、李傳珍,本校(含附醫),抗發炎/血管新生/轉移/腫瘤之動物模式的建立,2020.8.1~2021.7.31 2020 . 08
30 個別型,DMR-110-004,林靖婷(Ching-Ting Lin)、王禎佑(Chen-Yu Wang),附醫院內計畫,篩選可抑制鼻竇內致病菌生物膜形成之中藥,2020.8.1~2021.7.31 2020 . 08
31 個別型,DMR-110-165,黃升騰(Sheng-Teng Huang)、林宏任(Hung-jen Lin),附醫院內計畫,丹參透過調控小鼠腸道微生物菌相,加強樂衛瑪抗肝癌的作用,2020.8.1~2021.6.30 2020 . 08
32 個別型,M09G1036,林聖興(Sheng-Shing Lin)、黃維德(Wei-Te Huang)、林于娟(Ling yu chuan)、洪皓脩(Hao-Hsiu Hung)、歐世宸(Ou Shi Chen)、鄭惟仁(Wei-Zen Cheng)、陳昭憲(Chen Chao-Hsien)、黃鐙儀(HUANG TENG-I)、林宏恩(Lin Hung-En)、林亭延(Lin Ting yen),衛福部,建構智慧中醫及應用模式計畫,2020.1.1~2020.12.15 2020 . 01
33 個別型,MOHW-109-CMA-03,孫茂峰(Mao-Feng Sun)、賴榮年(Jung-Nien Lai)、林嘉德(Chia-Der Lin)、邱德發(Te-Fa Chiu)、顏宏融(Hung-Rong Yen)、羅綸謙(Lun-Chien Lo)、張東廸(Tung-Ti Chang)、林宏任(Hung-jen Lin)、蘇珊玉(Shan-Yu Su)、李育臣(Yu-Chen Lee)、黃敬軒(Ching-Hsuan Huang)、黃國欽(Huang, Kuo-Chin)、徐新政(Hsu, Hsin-Cheng)、林聖興(Sheng-Shing Lin)、侯甫葦(Pu-Wei Hou)、蔡邱轔(Chiu-Lin Tsai)、吳旻峰(Min-Feng Wu)、涂慶業(Chin-Yeh Tu)、詹士賢(Shyh-Shyan Jan)、李雅玲(Ya-Ling Lee)、何婧嫙(Ching-Hsuan Ho),衛福部,109年度中醫臨床技能評估及臨床教學網絡計畫,2020.1.20~2020.12.15 2020 . 01
34 個別型,MOHW108-CMAP-M-212-000103,孫茂峰(Mao-Feng Sun)、賴榮年(Jung-Nien Lai)、林嘉德(Chia-Der Lin)、邱德發(Te-Fa Chiu)、顏宏融(Hung-Rong Yen)、羅綸謙(Lun-Chien Lo)、張東廸(Tung-Ti Chang)、林宏任(Hung-jen Lin)、李育臣(Yu-Chen Lee)、徐新政(Hsin-Cheng Hsu)、蘇珊玉(Shan-Yu Su)、黃國欽(Huang, Kuo-Chin)、林聖興(Sheng-Shing Lin)、黃敬軒(Ching-Hsuan Huang)、侯甫葦(Pu-Wei Hou)、蔡邱轔(Chiu-Lin Tsai)、吳旻峰(Min-Feng Wu)、涂慶業(Chin-Yeh Tu)、詹士賢(Shyh-Shyan Jan)、李雅玲(Ya-Ling Lee)、邱奕笙(Yi-Sheng Ciou)、陳暐棣(Wei-Di Chen)、洪瑞鴻(HUNG JUI-HUNG)、吳美瑤(Mei-Yao Wu)、何婧嫙(Ching-Hsuan Ho),衛福部,108年度「輔導中醫臨床技能評估模式及臨床教學實務訓練計畫」,2019.1.25~2019.12.25 2019 . 01
35 個別型,DMR-108-044,黃升騰(Sheng-Teng Huang),附醫院內計畫,中醫大腸癌臨床醫案大數據分析,2018.8.1~2019.7.31 2018 . 08
36 個別型,MOHW107-CMAP-M-211-000103,張恒鴻(Chang, Hen-Hong)、林嘉德(Lin, Chia-Der)、方信元(Fang, Hsin-Yuan)、黃升騰(Huang, Sheng-Teng)、顏宏融(Yen, Hung-Rong)、張東廸(Chang, Tung-Ti)、林宏任(Lin, Hung-Jen)、李育臣(Lee, Yu-Chen)、徐新政(Hsu, Hsin-Cheng)、蘇珊玉(Su, Shan-Yu)、黃國欽(Huang, kuo-Chin)、林聖興(Lin, Sheng-Shing)、侯甫葦(Pu-Wei Ho)、蔡邱轔(Chiu-Lin Tsai),衛福部,107年度「輔導中醫臨床技能評估模式及臨床教學實務訓練計畫」,2018.1.25~2018.12.15 2018 . 01
37 國家型,CMRC-CHM-0,黃升騰(Sheng-Teng Huang)、李家琳(Chia-Lin Lee)、林振文(Lin Cheng Wen)、趙嶸(Chao, Jung)、湯智昕(Chih-Hsin Tang)、謝文聰、郭悅雄(Yueh-Hsiung Kuo)、郭盛助(Sheng-Chu kuo)、王陸海(Liu-Hai Wang)、佘玉萍(Yuh-Pyng Sher)、許游章(You-Cheng Hseu)、高銘欽(Ming-Ching Kao),教育部,中醫藥研究中心-中草藥研究群組,2018.1.1~2018.12.31 2018 . 01
38 個別型,MOST 106-2320-B-039-026-,,科技部,丹參酮IIA抑制腫瘤效應:經由粒線體誘發細胞凋亡及經由抑制PI3K/Akt/mTOR逕路自噬反應之細胞及動物模型研究,2017.8.1~2018.7.31 2017 . 08
39 個別型,DMR-107-006,,附醫院內計畫,探討cryptotanshinone限制腫瘤之生長經抑制M2巨噬細胞分化並調控金屬蛋白酶及轉化生長因子-β表現以致抗血管新生,2017.8.1~2018.7.31 2017 . 08
40 個別型,MOHW106-CMAP-M-211-000103,張恒鴻(CHANG,HEN-HONG)、林嘉德(Chia-Der Lin)、方信元(Hsin-Yuan Fang)、黃升騰(Huang, Sheng-Teng)、顏宏融(Hung-Rong Yen)、張東廸(Tung-Ti Chang)、林宏任(Lin Hung-jen)、李育臣(Yu-Chen Lee)、徐新政(Hsin-Cheng Hsu)、蘇珊玉(Shan-Yu Su)、黃國欽(kuo-Chin Huang)、侯甫葦(Pu-Wei Ho)、蔡邱轔(Chiu-Lin Tsai)、何婧嫙(Ching-Hsuan Ho),衛福部,輔導中醫臨床技能評估模式及教學實務訓練計畫,2017.1.9~2017.12.15 2017 . 01
41 個別型,106-2-N003,夏德椿(Te-Chun Hsia)、林宏任(Lin Hung-jen)、何文照(Wen-Chao Ho)、王禎佑(WANG,CHEN-YU),衛福部,106年度「常見疾病之中醫證型研究」科技委託研幾究計畫,2017.1.19~2018.1.18 2017 . 01
42 國家型,NA,謝慶良(Ching-Liang Hsieh)、林以文(Lin, Yi-Wen)、蘇冠賓(Kuan-Pin Su)、温永銳(Yeong-Ray Wen)、陳易宏、李家琳(Chia-Lin Lee)、郭盛助(Sheng-Chu kuo)、佘玉萍(Yuh-Pyng Sher)、郭悅雄(Yueh-Hsiung Kuo)、許游章(You-Cheng Hseu)、林振文(Lin Cheng Wen)、黃升騰(Sheng-Teng Huang)、謝文聰、高銘欽(Ming-Ching Kao)、高尚德(Shung-Te Kao),教育部,中醫藥研究中心,2017.1.1~2017.12.31 2017 . 01
43 整合型(召集人、總主持人),1055918L,高銘欽(Ming-Ching Kao)、周聖杰(Shen-Chieh Chou),本校(含附醫),校務準備金-PHY606為缺鐵性貧血的輔助藥物開發-子計畫一,2016.12.1~2017.7.31 2016 . 12
44 個別型,MOST 105-2320-B-039-035-,張恒鴻、林祖功,科技部,隱丹參酮抑制腫瘤效應研究:經由調控粒線體動態條件改變及活化細胞凋亡與自噬反應,2016.8.1~2017.7.31 2016 . 08
45 個別型,DMR-106-005,張恒鴻(CHANG,HEN-HONG)、藍忠亮(Joung-Liang Lan),附醫院內計畫,柚皮苷在類風濕性關節炎上之抗發炎作用及可能機轉,2016.8.1~2017.7.31 2016 . 08
46 個別型,採購案號:M05G9040,黃秋錦(Chiu-Ching Huang)、孫茂峰(SUN, MAO-FENG)、張志宗(Chiz-Tzung Chang)、黃升騰(Huang, Sheng-Teng)、王怡寬(I-Kuan Wang)、黃國欽(kuo-Chin Huang)、郭慧亮(Huey-Liang kuo)、林宏任(Lin Hung-jen)、劉耀隆(Yao-Lung Liu)、李育臣(Yu-Chen Lee)、周哲毅(Che-Yi Chou)、丁羿文(I-Wen Ting)、楊雅斐(Ya-Fei Yang)、廖元敬(Yuan-Ching Liao)、李艾玲(Ai-Lin Lee)、楊潤(Jun Yang),衛福部,105年度「促進中醫多元發展」委託科技研究計劃,分項3:建構中醫日間照護模式計畫,2016.1.19~2016.12.15 2016 . 01

專利技術

專利/Patent
(專利名稱,專利類別,專利國別,專利號碼,專利期間)
日期
1 用於治療和預防 SARS-CoV-2 病毒感染的草藥組合物,發明專利,台灣、美洲,I830493,2024.1.21~2042.11.10 2024 . 01
2 一種針具回收數量計算裝置,新型專利,台灣,M644752,2023.8.11~2032.12.6 2023 . 08
3 一種中醫智能處方系統與方法,發明專利,台灣,I797477,2023.4.1~2040.9.13 2023 . 04
4 一種中醫智能處方裝置,新型專利,台灣,M617562,2021.10.1~2030.9.13 2021 . 10

獲獎事蹟

獲獎/Award
(獲獎名稱,給獎單位,獲獎日期)
日期
1 第二十屆國家新創獎 臨床新創獎,財團法人生技醫療科技政策研究中心,2023.12.27 2023 . 12
2 第十九屆國家新創獎 臨床新創獎,財團法人生技醫療科技政策研究中心,2022.12.3 2022 . 12
3 衛福部110年中醫藥發展獎勵第一屆玉階獎-創新貢獻獎,衛福部,2021.12.17 2021 . 12
4 第十七屆國家新創獎 臨床新創獎,財團法人生技醫療科技政策研究中心,2020.12.1 2020 . 12

技術轉移

暫無資料
至頂